Xencor, Inc Lessee, Operating Lease, Liability, to be Paid, Year One
Xencor, Inc (XNCR) had Lessee, Operating Lease, Liability, to be Paid, Year One of $9.76 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-05
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $9.76M.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $9.76M.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $7.82M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $9.08M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $9.76M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $9.76M 10-Q · filed 2026-05-06 |
| 2025-12-31 | $7.82M 10-K · filed 2026-02-25 |
| 2025-09-30 | $9.08M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $6.70M 10-Q · filed 2025-08-06 |
| 2025-03-31 | $6.70M 10-Q · filed 2025-05-07 |
| 2024-12-31 | $7.45M 10-K · filed 2025-02-27 |
| 2024-09-30 | $8.02M 10-Q/A · filed 2025-02-24 |
| 2024-06-30 | $8.02M 10-Q/A · filed 2025-02-24 |
| 2024-03-31 | $8.02M 10-Q/A · filed 2025-02-24 |
| 2023-12-31 | $6.13M 10-K/A · filed 2025-02-24 |
| 2023-09-30 | $6.68M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $6.07M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $6.07M 10-Q · filed 2023-05-08 |
| 2022-12-31 | $6.56M 10-K · filed 2023-02-27 |
| 2022-09-30 | $7.25M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $6.80M 10-Q · filed 2022-08-03 |
| 2022-03-31 | $5.57M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $2.10M 10-K · filed 2022-02-24 |
| 2021-09-30 | $2.34M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $2.09M 10-Q · filed 2021-08-04 |
| 2021-03-31 | $2.27M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $2.43M 10-K · filed 2021-02-24 |
| 2020-09-30 | $2.65M 10-Q · filed 2020-11-06 |
| 2019-12-31 | $2.70M 10-K · filed 2020-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |